Inhibrx Biosciences, Inc.
Non-immunogenic single domain antibodies

Last updated:

Abstract:

The invention provides modifications within human or humanized single domain antibody fragments (sdAbs) that prevent recognition by pre-existing antibodies, to isolated polypeptides that include these modifications, and to methods and uses thereof.

Status:
Grant
Type:

Utility

Filling date:

21 Jan 2016

Issue date:

7 Jan 2020